2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Platinum Chemotherapy Induces Lymphangiogenesis in Cancerous and Healthy Tissues That Can be Prevented With Adjuvant Anti-VEGFR3 Therapy

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Chemotherapy has been used to inhibit cancer growth for decades, but emerging evidence shows it can affect the tumor stroma, unintentionally promoting cancer malignancy. After treatment of primary tumors, remaining drugs drain via lymphatics. Though all drugs interact with the lymphatics, we know little of their impact on them. Here, we show a previously unknown effect of platinums, a widely used class of chemotherapeutics, to directly induce systemic lymphangiogenesis and activation. These changes are dose-dependent, long-lasting, and occur in healthy and cancerous tissue in multiple mouse models of breast cancer. We found similar effects in human ovarian and breast cancer patients whose treatment regimens included platinums. Carboplatin treatment of healthy mice prior to mammary tumor inoculation increased cancer metastasis as compared to no pre-treatment. These platinum-induced phenomena could be blocked by VEGFR3 inhibition. These findings have implications for cancer patients receiving platinums and may support the inclusion of anti-VEGFR3 therapy into treatment regimens or differential design of treatment regimens to alter these potential effects.

          Related collections

          Most cited references70

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          STRING v10: protein–protein interaction networks, integrated over the tree of life

          The many functional partnerships and interactions that occur between proteins are at the core of cellular processing and their systematic characterization helps to provide context in molecular systems biology. However, known and predicted interactions are scattered over multiple resources, and the available data exhibit notable differences in terms of quality and completeness. The STRING database (http://string-db.org) aims to provide a critical assessment and integration of protein–protein interactions, including direct (physical) as well as indirect (functional) associations. The new version 10.0 of STRING covers more than 2000 organisms, which has necessitated novel, scalable algorithms for transferring interaction information between organisms. For this purpose, we have introduced hierarchical and self-consistent orthology annotations for all interacting proteins, grouping the proteins into families at various levels of phylogenetic resolution. Further improvements in version 10.0 include a completely redesigned prediction pipeline for inferring protein–protein associations from co-expression data, an API interface for the R computing environment and improved statistical analysis for enrichment tests in user-provided networks.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            DIANA-miRPath v3.0: deciphering microRNA function with experimental support

            The functional characterization of miRNAs is still an open challenge. Here, we present DIANA-miRPath v3.0 (http://www.microrna.gr/miRPathv3) an online software suite dedicated to the assessment of miRNA regulatory roles and the identification of controlled pathways. The new miRPath web server renders possible the functional annotation of one or more miRNAs using standard (hypergeometric distributions), unbiased empirical distributions and/or meta-analysis statistics. DIANA-miRPath v3.0 database and functionality have been significantly extended to support all analyses for KEGG molecular pathways, as well as multiple slices of Gene Ontology (GO) in seven species (Homo sapiens, Mus musculus, Rattus norvegicus, Drosophila melanogaster, Caenorhabditis elegans, Gallus gallus and Danio rerio). Importantly, more than 600 000 experimentally supported miRNA targets from DIANA-TarBase v7.0 have been incorporated into the new schema. Users of DIANA-miRPath v3.0 can harness this wealth of information and substitute or combine the available in silico predicted targets from DIANA-microT-CDS and/or TargetScan v6.2 with high quality experimentally supported interactions. A unique feature of DIANA-miRPath v3.0 is its redesigned Reverse Search module, which enables users to identify and visualize miRNAs significantly controlling selected pathways or belonging to specific GO categories based on in silico or experimental data. DIANA-miRPath v3.0 is freely available to all users without any login requirement.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              ConsensusPathDB—a database for integrating human functional interaction networks

              ConsensusPathDB is a database system for the integration of human functional interactions. Current knowledge of these interactions is dispersed in more than 200 databases, each having a specific focus and data format. ConsensusPathDB currently integrates the content of 12 different interaction databases with heterogeneous foci comprising a total of 26 133 distinct physical entities and 74 289 distinct functional interactions (protein–protein interactions, biochemical reactions, gene regulatory interactions), and covering 1738 pathways. We describe the database schema and the methods used for data integration. Furthermore, we describe the functionality of the ConsensusPathDB web interface, where users can search and visualize interaction networks, upload, modify and expand networks in BioPAX, SBML or PSI-MI format, or carry out over-representation analysis with uploaded identifier lists with respect to substructures derived from the integrated interaction network. The ConsensusPathDB database is available at: http://cpdb.molgen.mpg.de
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Oncol
                Front Oncol
                Front. Oncol.
                Frontiers in Oncology
                Frontiers Media S.A.
                2234-943X
                17 March 2022
                2022
                : 12
                : 801764
                Affiliations
                [1] 1 Department of Obstetrics and Gynecology, Gynecologic Oncology Division, University of Virginia , Charlottesville, VA, United States
                [2] 2 Department of Pathology, University of Virginia , Charlottesville, VA, United States
                [3] 3 Department of Biomedical Engineering & Mechanics, Fralin Biomedical Research Institute, Virginia Polytechnic Institute and State University , Roanoke, VA, United States
                [4] 4 Department of Biomedical Engineering, University of Virginia , Charlottesville, VA, United States
                [5] 5 Department of Microbiology, Immunology, and Cancer Biology, University of Virginia , Charlottesville, VA, United States
                [6] 6 Department of Chemistry, University of Virginia , Charlottesville, VA, United States
                [7] 7 Department of Genetics & Genome Sciences, Lerner Research Institute , Cleveland, OH, United States
                [8] 8 Department of Pathology and Laboratory Medicine, Brown University , Providence, RI, United States
                [9] 9 Department of Pathology and Laboratory Medicine, Women & Infants Hospital of Rhode Island , Providence, RI, United States
                [10] 10 Department of Hematology and Oncology, University of Virginia , Charlottesville, VA, United States
                Author notes

                Edited by: Angela Toss, University of Modena and Reggio Emilia, Italy

                Reviewed by: Lasse Dahl Ejby Jensen, Linköping University, Sweden; Monika Ehnman, Karolinska Institutet (KI), Sweden

                *Correspondence: Jennifer M. Munson, Jm4kt@ 123456vt.edu

                This article was submitted to Breast Cancer, a section of the journal Frontiers in Oncology

                Article
                10.3389/fonc.2022.801764
                8970967
                35372032
                13402779-2214-4944-9537-4ae3fa8f03e5
                Copyright © 2022 Harris, Esparza, Azimi, Cornelison, Azar, Llaneza, Belanger, Mathew, Tkachenko, Perez, Rosean, Bostic, Cornelison, Tate, Peirce-Cottler, Paquette, Mills, Landen, Saucerman, Dillon, Pompano, Rutkowski and Munson

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 25 October 2021
                : 31 January 2022
                Page count
                Figures: 6, Tables: 0, Equations: 0, References: 70, Pages: 17, Words: 8893
                Categories
                Oncology
                Original Research

                Oncology & Radiotherapy
                platinum,chemotherapy,lymphangiogenesis,metastasis,breast cancer,ovarian cancer,lymphatic endothelial cells,anti-vegfr3 therapy

                Comments

                Comment on this article